Literature DB >> 14552542

Potential of phosphorus nuclear magnetic resonance spectroscopy in studies of the energy metabolism of skeletal muscles.

S K Ternovoi1, T N Veselova, V E Sinitsin.   

Abstract

The aim of the present study was to investigate the possibility of phosphorus magnetic resonance spectroscopy (MR spectroscopy) in the diagnosis of metabolic lesions of skeletal musculature in patients with intermittent claudication syndrome, chronic cardiac failure, and varicose diseases of the lower limbs. Studies included 50 males: 20 patients with intermittent claudication, 10 patients with chronic cardiac failure, and 10 patients with varicose veins. The control group consisted of 10 healthy volunteers. The following measures were determined: the phosphocreatinine index, the intracellular pH in the gastrocnemius muscle, and the half-recovery time for the phosphocreatinine index. The phosphocreatinine index and the pH at rest did not differ between study groups. Isotonic exercise produced no change in the phosphocreatinine index in the control group; patients with intermittent claudication showed a 26.1% decrease, patients with chronic cardiac failure showed an 8% decrease, and patients with varicose veins showed a 25.6% decrease. The only group showing a significant decrease in pH during exercise was the group of patients with intermittent claudication. This group also showed an inverse correlation between the pressure index and the extent of the decrease in the phosphocreatinine index. Thus, MR spectroscopy provides a non-invasive diagnostic method for lesions of energy metabolism in skeletal musculature in patients with deranged peripheral hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14552542     DOI: 10.1023/a:1024425210713

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  9 in total

Review 1.  Clinical nuclear magnetic resonance spectroscopy: insight into metabolism.

Authors:  S Schaefer
Journal:  Am J Cardiol       Date:  1990-10-26       Impact factor: 2.778

Review 2.  The mechanism of extertional fatigue in heart failure.

Authors:  J R Wilson; D M Mancini
Journal:  Cardioscience       Date:  1990-03

3.  Changes in calf muscle performance, energy metabolism, and muscle volume caused by long-term stay on space station MIR.

Authors:  J Zange; K Müller; M Schuber; H Wackerhage; U Hoffmann; R W Günther; G Adam; J M Neuerburg; V E Sinitsyn; A O Bacharev; O I Belichenko
Journal:  Int J Sports Med       Date:  1997-10       Impact factor: 3.118

4.  Phosphorus magnetic resonance spectroscopy: a noninvasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy.

Authors:  D G Wahl; J P Simon; B Robin; P Walker; P Jouanny; J M Escanye; F Paille; C Schmidt; F Brunotte; J Robert
Journal:  Angiology       Date:  1994-05       Impact factor: 3.619

5.  Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study.

Authors:  D J Taylor; P J Bore; P Styles; D G Gadian; G K Radda
Journal:  Mol Biol Med       Date:  1983-07

6.  Skeletal muscle metabolism in heart failure: a 31P nuclear magnetic resonance spectroscopy study of leg muscle.

Authors:  L Arnolda; M Conway; M Dolecki; H Sharif; B Rajagopalan; J G Ledingham; P Sleight; G K Radda
Journal:  Clin Sci (Lond)       Date:  1990-12       Impact factor: 6.124

7.  Peripheral arterial occlusive disease: P-31 MR spectroscopy of calf muscle.

Authors:  D M Williams; L Fencil; T L Chenevert
Journal:  Radiology       Date:  1990-05       Impact factor: 11.105

8.  Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance.

Authors:  J R Wilson; L Fink; J Maris; N Ferraro; J Power-Vanwart; S Eleff; B Chance
Journal:  Circulation       Date:  1985-01       Impact factor: 29.690

9.  Assessment of muscular metabolism in peripheral arterial occlusive disease using 31P nuclear magnetic resonance spectroscopy. Comparison with metabolite concentrations in femoral blood.

Authors:  W Rexroth; W Semmler; F Gückel; M Stadtlander; H Weicker; R Hild; G van Kaick
Journal:  Klin Wochenschr       Date:  1989-08-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.